Bioqual, Inc.
BIOQ · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -16.6% | -6.5% | -5.3% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -3.9% | 12.7% | 20.1% | 19.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 1% | 5.2% | 11.1% | 22.3% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -2.1% | 0.8% | 1.3% | 8% |
| EPS Diluted | -1.17 | 0.54 | 0.93 | 5.88 |
| % Growth | -316.7% | -41.9% | -84.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |